These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16414022)

  • 1. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis.
    Enayetallah AE; Grant DF
    Biochem Biophys Res Commun; 2006 Mar; 341(1):254-60. PubMed ID: 16414022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in human soluble epoxide hydrolase.
    Przybyla-Zawislak BD; Srivastava PK; Vazquez-Matias J; Mohrenweiser HW; Maxwell JE; Hammock BD; Bradbury JA; Enayetallah AE; Zeldin DC; Grant DF
    Mol Pharmacol; 2003 Aug; 64(2):482-90. PubMed ID: 12869654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure.
    Srivastava PK; Sharma VK; Kalonia DS; Grant DF
    Arch Biochem Biophys; 2004 Jul; 427(2):164-9. PubMed ID: 15196990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues.
    Enayetallah AE; French RA; Barber M; Grant DF
    J Histochem Cytochem; 2006 Mar; 54(3):329-35. PubMed ID: 16314446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase.
    Tran KL; Aronov PA; Tanaka H; Newman JW; Hammock BD; Morisseau C
    Biochemistry; 2005 Sep; 44(36):12179-87. PubMed ID: 16142916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism.
    DuTeaux SB; Newman JW; Morisseau C; Fairbairn EA; Jelks K; Hammock BD; Miller MG
    Toxicol Sci; 2004 Apr; 78(2):187-95. PubMed ID: 14737000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase.
    EnayetAllah AE; Luria A; Luo B; Tsai HJ; Sura P; Hammock BD; Grant DF
    J Biol Chem; 2008 Dec; 283(52):36592-8. PubMed ID: 18974052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatase activity of soluble epoxide hydrolase.
    Kramer J; Proschak E
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():88-92. PubMed ID: 28729091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
    Imig JD
    Cardiovasc Drug Rev; 2006; 24(2):169-88. PubMed ID: 16961727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Biochemistry; 2004 Apr; 43(16):4716-23. PubMed ID: 15096040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical study of the full reaction mechanism of human soluble epoxide hydrolase.
    Hopmann KH; Himo F
    Chemistry; 2006 Sep; 12(26):6898-909. PubMed ID: 16856182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.
    Ohtoshi K; Kaneto H; Node K; Nakamura Y; Shiraiwa T; Matsuhisa M; Yamasaki Y
    Biochem Biophys Res Commun; 2005 May; 331(1):347-50. PubMed ID: 15845398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids.
    Morisseau C; Schebb NH; Dong H; Ulu A; Aronov PA; Hammock BD
    Biochem Biophys Res Commun; 2012 Mar; 419(4):796-800. PubMed ID: 22387545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase.
    Cronin A; Mowbray S; Dürk H; Homburg S; Fleming I; Fisslthaler B; Oesch F; Arand M
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1552-7. PubMed ID: 12574508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of Xenopus soluble epoxide hydrolase.
    Purba ER; Oguro A; Imaoka S
    Biochim Biophys Acta; 2014 Jul; 1841(7):954-62. PubMed ID: 24681163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling.
    Decker M; Arand M; Cronin A
    Arch Toxicol; 2009 Apr; 83(4):297-318. PubMed ID: 19340413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved radiolabeled substrates for soluble epoxide hydrolase.
    Borhan B; Mebrahtu T; Nazarian S; Kurth MJ; Hammock BD
    Anal Biochem; 1995 Oct; 231(1):188-200. PubMed ID: 8678300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble epoxide hydrolase and lipid metabolism].
    Ma XX; Liu Y; Zhu Y
    Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):267-71. PubMed ID: 21416942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.
    Hou HH; Hammock BD; Su KH; Morisseau C; Kou YR; Imaoka S; Oguro A; Shyue SK; Zhao JF; Lee TS
    Cardiovasc Res; 2012 Jan; 93(1):120-9. PubMed ID: 22072631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the catalytic mechanism of human sEH phosphatase by site-directed mutagenesis and LC-MS/MS analysis.
    Cronin A; Homburg S; Dürk H; Richter I; Adamska M; Frère F; Arand M
    J Mol Biol; 2008 Nov; 383(3):627-40. PubMed ID: 18775727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.